LIFR and hepatocellular carcinoma: In addition, we showed that the addition of EC359, a LIFR inhibitor [35] did not impact the inhibitory effect of CVB‐D on LIF and the protein expression of LIFR and gp130 in HCC cells (Figure S3I).